Physiomics (LON:PYC) Stock Price Up 4.9% – Should You Buy?

Physiomics Plc (LON:PYC)’s share price rose 4.9% during mid-day trading on Thursday . The company traded as high as GBX 0.58 and last traded at GBX 0.58. Approximately 4,705,372 shares were traded during trading, a decline of 35% from the average daily volume of 7,210,546 shares. The stock had previously closed at GBX 0.55.

Physiomics Price Performance

The stock’s fifty day moving average is GBX 0.48 and its 200-day moving average is GBX 0.41. The stock has a market cap of £2.72 million, a PE ratio of -4.00 and a beta of 0.95.

Physiomics (LON:PYC) last announced its quarterly earnings data on Monday, February 16th. The company reported GBX (0.10) earnings per share (EPS) for the quarter. Physiomics had a negative net margin of 50.92% and a negative return on equity of 89.43%. On average, sell-side analysts expect that Physiomics Plc will post -0.13 EPS for the current fiscal year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.